BDX vs. BSX
BDX (Becton, Dickinson and Company) and BSX (Boston Scientific Corporation) are both stocks. Both are in the Healthcare sector — BDX in Medical Instruments & Supplies, BSX in Medical Devices. Over the past 10 years, BDX returned 2.71%/yr vs 7.66%/yr for BSX. At a 0.34 correlation, their price movements are largely independent.
Performance
BDX vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BDX achieves a -3.95% return, which is significantly higher than BSX's -49.98% return. Over the past 10 years, BDX has underperformed BSX with an annualized return of 2.71%, while BSX has yielded a comparatively higher 7.66% annualized return.
BDX
- 1D
- 0.82%
- 1M
- -0.48%
- YTD
- -3.95%
- 6M
- -3.18%
- 1Y
- 11.08%
- 3Y*
- -8.04%
- 5Y*
- -3.03%
- 10Y*
- 2.71%
BSX
- 1D
- 0.02%
- 1M
- -16.11%
- YTD
- -49.98%
- 6M
- -51.62%
- 1Y
- -53.74%
- 3Y*
- -2.73%
- 5Y*
- 2.56%
- 10Y*
- 7.66%
BDX vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BDX Becton, Dickinson and Company | -3.95% | -12.61% | -5.38% | -2.67% | 5.08% | 1.88% | -6.75% | 22.20% | 6.61% | 31.24% |
BSX Boston Scientific Corporation | -49.98% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between BDX and BSX is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.47 |
Correlation (All Time) Calculated using the full available price history since May 20, 1992 | 0.34 |
The correlation between BDX and BSX shifts across timeframes, from 0.28 (1 year) to 0.47 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
BDX:
$40.86B
BSX:
$71.30B
BDX:
$3.99
BSX:
$2.38
BDX:
36.52
BSX:
20.07
BDX:
1.94
BSX:
3.46
BDX:
1.69
BSX:
2.76
BDX:
$21.37B
BSX:
$20.62B
BDX:
$9.93B
BSX:
$14.52B
BDX:
$4.16B
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BDX vs. BSX — Risk / Return Rank
BDX
BSX
BDX vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Becton, Dickinson and Company (BDX) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BDX | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.00 | ||
| Sortino ratioReturn per unit of downside risk | +3.31 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 0.65 | +0.45 |
| Calmar ratioReturn relative to maximum drawdown | 0.49 | -0.96 | +1.45 |
| Martin ratioReturn relative to average drawdown | 1.19 | -2.19 | +3.38 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BDX | BSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.45 | -1.56 | +2.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.13 | 0.10 | -0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.12 | 0.28 | -0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.19 | +0.23 |
Drawdowns
BDX vs. BSX - Drawdown Comparison
The maximum BDX drawdown since its inception was -51.17%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for BDX and BSX.
Loading charts...
Drawdown Indicators
| BDX | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.17% | -89.15% | +37.98% |
Max Drawdown (1Y)Largest decline over 1 year | -22.73% | -55.91% | +33.18% |
Max Drawdown (3Y)Largest decline over 3 years | -40.06% | -55.91% | +15.85% |
Max Drawdown (5Y)Largest decline over 5 years | -40.06% | -55.91% | +15.85% |
Max Drawdown (10Y)Largest decline over 10 years | -40.06% | -55.91% | +15.85% |
Current DrawdownCurrent decline from peak | -31.20% | -55.90% | +24.70% |
Average DrawdownAverage peak-to-trough decline | -11.57% | -38.75% | +27.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.31% | 24.56% | -15.25% |
Volatility
BDX vs. BSX - Volatility Comparison
The current volatility for Becton, Dickinson and Company (BDX) is 9.74%, while Boston Scientific Corporation (BSX) has a volatility of 16.20%. This indicates that BDX experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BDX | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.74% | 16.20% | -6.46% |
Volatility (6M)Calculated over the trailing 6-month period | 18.17% | 32.82% | -14.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.85% | 34.63% | -9.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.25% | 25.66% | -2.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.55% | 27.29% | -3.74% |
Dividends
BDX vs. BSX - Dividend Comparison
BDX's dividend yield for the trailing twelve months is around 2.41%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BDX Becton, Dickinson and Company | 2.41% | 2.15% | 1.71% | 1.51% | 1.38% | 1.34% | 1.28% | 1.14% | 1.34% | 1.37% | 1.64% | 1.60% |
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BDX vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Becton, Dickinson and Company and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BDX vs. BSX - Profitability Comparison
BDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Becton, Dickinson and Company reported a gross profit of 2.15B and revenue of 4.71B. Therefore, the gross margin over that period was 45.7%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
BDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Becton, Dickinson and Company reported an operating income of 94.00M and revenue of 4.71B, resulting in an operating margin of 2.0%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
BDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Becton, Dickinson and Company reported a net income of -311.00M and revenue of 4.71B, resulting in a net margin of -6.6%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
BDX and BSX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BSX has higher volatility (16.20%) compared to BDX (9.74%). In terms of maximum drawdown, BDX dropped -51.17% vs BSX's -89.15%.
BDX currently has the higher Sharpe Ratio (0.45 vs -1.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BDX and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer